ZYBT
Zhengye Biotechnology Holding Limited
1.52
-0.02 (-1.30%)
52w low 0.6160
8.01 high
12.2% of range
Financial Analysis
| Ratio | Dec 21 | Dec 22 | Dec 23 | Dec 24 | Dec 25 | Trend |
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross Margin | -- | 56.8% | 55.5% | 49.0% | 20.5% | |
| Operating Margin | -- | 25.4% | 22.5% | 9.2% | -58.7% | |
| EBITDA Margin | -- | 32.9% | 34.1% | 22.9% | -36.5% | |
| Net Margin | -- | 18.0% | 14.9% | 6.1% | -60.0% | |
| FCF Margin | -- | -3.8% | 17.3% | 7.1% | 0.6% | |
| Returns | ||||||
| Return on Equity | -- | 15.8% | 11.5% | 4.0% | -27.9% | |
| Return on Assets | -- | 9.0% | 6.3% | 2.3% | -16.0% | |
| Return on Inv Capital | -- | 16.1% | 11.4% | 4.7% | -24.4% | |
| Liquidity | ||||||
| Current Ratio | -- | 1.41x | 1.26x | 1.31x | 1.14x | |
| Quick Ratio | -- | 1.04x | 0.87x | 0.88x | 0.82x | |
| Cash Ratio | -- | 0.06x | 0.10x | 0.14x | 0.42x | |
| Leverage | ||||||
| Debt / Equity | -- | 0.22x | 0.33x | 0.30x | 0.30x | |
| Net Debt / EBITDA | -- | 0.64x | 1.04x | 1.59x | -0.57x | |
| Interest Coverage | -- | 23.51x | 10.89x | 4.56x | -20.14x | |
| Equity Multiplier | -- | 1.75x | 1.83x | 1.74x | 1.75x | |
| Efficiency | ||||||
| Asset Turnover | -- | 0.50x | 0.42x | 0.38x | 0.27x | |
| Inventory Turnover | -- | 2.03x | 1.61x | 1.63x | 2.36x | |
| Effective Tax Rate | -- | 12.8% | 14.3% | 6.4% | -15.4% | |
| Op CF / Net Income | -- | 0.37x | 1.53x | 3.63x | -0.19x | |
| Investment | ||||||
| Capex / Revenue | -- | 10.5% | 5.5% | 14.9% | 10.9% | |
| R&D / Revenue | -- | 5.2% | 5.6% | 6.9% | 15.5% | |
| SG&A / Revenue | -- | 22.6% | 30.4% | 34.3% | 64.4% | |
Revenue CAGR
-23.5%
Net Income CAGR
--
EPS CAGR
-33.8%
FCF CAGR
--
Revenue YoY
-37.6%